-
Publication Venue For
-
Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials..
34:623-634.
2019
-
Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study.
33:1175-1182.
2018
-
Antenatal paternal adjustment and paternal attitudes after infertility treatment..
33:109-115.
2018
-
Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
32:2049-2055.
2017
-
Donor-conceived children: the view ahead.
32:1534-1534.
2017
-
Donor-conceived children: the view ahead..
32:1534.
2017
-
Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype..
29:2680-2686.
2014
-
Unconditioned commercial embryo culture media contain a large variety of non-declared proteins: a comprehensive proteomics analysis..
29:2421-2430.
2014
-
Agreement between self-reported use of in vitro fertilization or ovulation induction, and medical insurance claims in Australian women aged 28-36 years..
27:2823-2828.
2012
-
High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples..
27:814-828.
2012
-
Embryo culture media and neonatal birthweight following IVF..
27:375-379.
2012
-
Examining the relationship between ovarian reserve, as measured by basal FSH levels, and the risk of poor obstetric outcome in singleton IVF gestations.
26:3424-3430.
2011
-
Cholesterol, endocrine and metabolic disturbances in sporadic anovulatory women with regular menstruation.
26:423-430.
2011
-
In utero exposure to maternal smoking and women's risk of fetal loss in the Norwegian Mother and Child Cohort (MoBa)..
26:458-465.
2011
-
Factors influencing physicians' advice about female sterilization in USA: a national survey..
26:106-111.
2011
-
Health disparities in risk for cervical insufficiency..
25:2894-2900.
2010
-
Severity and duration of nausea and vomiting symptoms in pregnancy and spontaneous abortion..
25:2907-2912.
2010
-
Y chromosome gr/gr deletions are a risk factor for low semen quality..
24:2667-2673.
2009
-
Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis.
20:1511-1515.
2005
-
Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?.
19:1697-1704.
2004
-
On the frequency of intercourse around ovulation: evidence for biological influences..
19:1539-1543.
2004
-
Mucus observations in the fertile window: a better predictor of conception than timing of intercourse..
19:889-892.
2004
-
Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study..
18:1223-1230.
2003
-
TwoDay Algorithm in predicting fertile time..
17:1925.
2002
-
Changes with age in the level and duration of fertility in the menstrual cycle..
17:1399-1403.
2002
-
The diaphragm with and without spermicide for contraception: a Cochrane review..
17:867-869.
2002
-
Acute ureteral obstruction following transvaginal oocyte retrieval for IVF..
17:137-138.
2002
-
Adolescent cancer patients: sperm storage, consent and emotion..
16:2473-2475.
2001
-
The relationship between cervical secretions and the daily probabilities of pregnancy: effectiveness of the TwoDay Algorithm..
16:2278-2282.
2001
-
Disposition of sperm donors with resultant abnormal pregnancies..
16:1553-1555.
2001
-
Adolescent cancer patients: sperm storage, consent and emotion.
16:2473.
2001
-
Ethics of postmortem sperm retrieval: ethics of sperm retrieval after death or persistent vegetative state..
15:739-745.
2000
-
Day-specific probabilities of clinical pregnancy based on two studies with imperfect measures of ovulation..
14:1835-1839.
1999
-
The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone..
14:1168-1174.
1999
-
Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions..
13:3206-3210.
1998
-
Semen quality: is there a paternal effect on pregnancy outcome in in-vitro fertilization/intracytoplasmic sperm injection?.
13:2161-2164.
1998
-
A prospective, randomized, double-blind study for the evaluation of assisted hatching in patients with advanced maternal age..
13:409-413.
1998
-
Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study..
13:33-38.
1998
-
Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination..
12:1886-1889.
1997
-
Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers..
12:1573-1576.
1997
-
Transfer of cryopreserved-thawed pre-embryos in a cycle using exogenous steroids without prior gonadotrophin-releasing hormone agonist suppression yields favourable pregnancy results..
12:1176-1180.
1997
-
Salpingectomy improves pregnancy rate in patients with hydrosalpinx.
11:2068-2069.
1996
-
A comparative analysis of embryo implantation potential in patients with severe teratozoospermia undergoing in-vitro fertilization with a high insemination concentration or intracytoplasmic sperm injection..
11:1086-1089.
1996
-
Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx..
11:523-525.
1996
-
Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene.
11:27-49.
1996
-
Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene.
11:27-54.
1996
-
Abnormal amniotic fetal antigen 2 concentrations in trisomy 18 and trisomy 21..
10:2438-2440.
1995
-
Cryopreservation: the problem of evaluation..
10:2136-2138.
1995
-
Evaluation of the spindle apparatus of in-vitro matured human oocytes following cryopreservation..
10:1816-1820.
1995
-
Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization..
9:235-240.
1994
-
Influence of number of pre-embryos transferred, progesterone level and oestradiol/progesterone ratio at thaw on pregnancy results during replacement of cryopreserved pre-embryos in natural cycles..
7:797-800.
1992
-
Sonographic appearance of the endometrium: the predictive value for the outcome of in-vitro fertilization in stimulated cycles..
7:677-680.
1992
-
Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases..
7:105-108.
1992
-
Ultrasonographic appearance of the endometrium in natural and stimulated in-vitro fertilization cycles and its correlation with outcome..
6:901-904.
1991
-
Analysis of ectopic pregnancies resulting from in-vitro fertilization and embryo transfer..
6:446-449.
1991
-
Controlled preparation of the endometrium with exogenous steroids for the transfer of frozen-thawed pre-embryos in patients with anovulatory or irregular cycles..
6:443-445.
1991
-
Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome..
6:284-289.
1991
-
Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression..
5:1004-1008.
1990
-
Non-functional ovarian cysts do not affect ipsilateral or contralateral ovarian performance during in-vitro fertilization..
5:431-433.
1990
-
In-vitro fertilization and embryo transfer in patients with endometriosis: impact of a gonadotrophin releasing hormone agonist..
4:541-544.
1989
-
O-056. The efficacy of intravaginal prostaglandin E1 (misoprostol) on pregnancy rates after intrauterine inseminations: a randomized controlled trial
1999